Navigation Links
Lexicon to Provide Third Quarter 2012 Financial Results
Date:10/31/2012

THE WOODLANDS, Texas, Oct. 31, 2012 /PRNewswire/ -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), announced today that it will release its third quarter 2012 financial results on Tuesday, November 6, 2012 before the financial markets open.  Lexicon management will hold a conference call and webcast to discuss financial results for the quarter and program status at 11:00 a.m. Eastern Time that same day.

The dial-in number for the conference call is 888-645-5785 (within the US/Canada) or 970-300-1531 (international).  The conference ID for all callers is 59736084.  Investors can access a live webcast of the call at www.lexpharma.com.  An archived version of the webcast will be available on Lexicon's corporate website at www.lexpharma.com through December 6, 2012.

About Lexicon

Lexicon is a biopharmaceutical company focused on discovering breakthrough treatments for human disease.  Lexicon currently has four drug programs in mid-stage development for diabetes, irritable bowel syndrome, carcinoid syndrome and rheumatoid arthritis, all of which were discovered by Lexicon's research team.  Lexicon has used its proprietary gene knockout technology to identify more than 100 promising drug targets.  Lexicon has focused drug discovery efforts on these biologically-validated targets to create its extensive pipeline of clinical and preclinical programs.  For additional information about Lexicon and its programs, please visit www.lexpharma.com.

Safe Harbor Statement

This press release contains "forward-looking" statements, including statements relating to Lexicon's growth and future operating results, discovery and development of products, strategic allianc
'/>"/>

SOURCE Lexicon Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Lexicon to Provide First Quarter 2012 Financial Results
2. Lexicon Pharmaceuticals Reports On Clinical Program Status And 2012 First Quarter Results
3. Lexicon Receives Funding for Phase 2 Clinical Trial of LX4211 in Type 1 Diabetes
4. Lexicon Pharmaceuticals to present at the Jefferies 2012 Global Healthcare Conference
5. Lexicon Presents Data Regarding the Mechanism of Action and Safety of LX4211 at American Diabetes Association Meeting
6. Lexicon Announces Positive Results of LX4211 Phase 2b Trial For Type 2 Diabetes
7. Lexicon Announces Publication of Results of Two Studies of LX4211 in Patients with Type 2 Diabetes in the Journal Clinical Pharmacology & Therapeutics
8. Lexicon to Provide Second Quarter 2012 Financial Results
9. Lexicon Pharmaceuticals Reports On Clinical Program Status And 2012 Second Quarter Results
10. Lexicon Pharmaceuticals To Present At The Wedbush PacGrow 2012 Management Access Conference
11. Lexicon Pharmaceuticals Reports Preliminary Results From Two Phase 1 Studies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... 2015 Olympus, a global technology leader ... and surgical procedures, among other core businesses, announced ... equipment at no additional charge. Olympus is the ... of guarantee. The service became available to customers ... year. Olympus, Full Service Agreement ...
(Date:6/30/2015)... , June 30, 2015 First Choice Wellness ... the Astanza Duality and is the only clinic in ... professional tattoo removal treatments. The practice has recently expanded ... brand to showcase their focus in the procedure. ... better results, faster ink clearance, and superior service. ...
(Date:6/30/2015)... June 30, 2015 Oramed Pharmaceuticals ... clinical-stage pharmaceutical Company focused on the development of oral ... has been screened in the Company,s Phase IIb trial ... study will be performed under the active Investigational New ... and Drug Administration (FDA). The Phase IIb ...
Breaking Medicine Technology:Olympus Introduces Industry-First Next-Day Product Replacement Guarantee for Surgical Business 2Olympus Introduces Industry-First Next-Day Product Replacement Guarantee for Surgical Business 3First Choice Wellness Care Becomes Tallahassee Leader In Tattoo Removal With Astanza Duality 2First Choice Wellness Care Becomes Tallahassee Leader In Tattoo Removal With Astanza Duality 3Oramed Enrolls First Patient in its Phase IIb Oral Insulin Study 2Oramed Enrolls First Patient in its Phase IIb Oral Insulin Study 3
... July 21, 2011 /PRNewswire-Asia-FirstCall/ -- Mindray Medical International Limited (NYSE: ... of medical devices worldwide, today announced that it will report ... 2011 after the U.S. market closes on August 8, 2011. ... AM on August 9, 2011 U.S. Eastern Time (8:00 PM ...
... advances impacting both individual lives and public health in ... announced the 2011 final candidates for the 5th annual ... the technical, scientific and clinical research skills necessary to ... industry,s highest accolade. Final candidates for the ...
Cached Medicine Technology:Mindray to Report Second Quarter 2011 Financial Results on August 8, 2011 22011 Prix Galien USA Final Candidates Announced: Competing for Best Biotechnology Product and Best Pharmaceutical Agent 2
(Date:6/30/2015)... ... June 30, 2015 , ... ... it has more than doubled the size of its medical staff to further ... staff -- which includes physicians, nurse practitioners and physician assistants -- now totals ...
(Date:6/30/2015)... , ... June 30, 2015 , ... ... currently pending in a federal multidistrict litigation now underway in the U.S. District ... next monthly Status Conference. According to the Court’s calendar, that conference has now ...
(Date:6/30/2015)... Plains, NJ (PRWEB) , ... June 30, 2015 , ... ... certified primary care sports medicine physician. He specializes in the diagnosis and treatment of ... athlete and for the people who participate in recreational athletics and use exercise to ...
(Date:6/30/2015)... ... 2015 , ... MJH Associates today welcomed Jim ... & Analytics , a consultative healthcare market research practice that is part of ... offers quantitative and qualitative, custom and multi-client primary market research services to support ...
(Date:6/30/2015)... ... June 30, 2015 , ... ... are partnering to improve access to cancer prevention, screening and care for the ... have announced an affiliation that will see Roswell Park faculty providing clinical consultations ...
Breaking Medicine News(10 mins):Health News:Lakeview Health, a Nationally Recognized Drug Rehabilitation Center in Florida, Doubles Size of Medical Staff 2Health News:Progress of Federal Xarelto Lawsuits Pending in Multidistrict Litigation to Be Discussed During July 9th Status Conference 2Health News:Progress of Federal Xarelto Lawsuits Pending in Multidistrict Litigation to Be Discussed During July 9th Status Conference 3Health News:NJ Top Docs Presents Dr. Sammy Masri; Dr. Masri is Now Offering a Wide Range of Services to his Valued Patients 2Health News:NJ Top Docs Presents Dr. Sammy Masri; Dr. Masri is Now Offering a Wide Range of Services to his Valued Patients 3Health News:NJ Top Docs Presents Dr. Sammy Masri; Dr. Masri is Now Offering a Wide Range of Services to his Valued Patients 4Health News:NJ Top Docs Presents Dr. Sammy Masri; Dr. Masri is Now Offering a Wide Range of Services to his Valued Patients 5Health News:HRA Healthcare Research & Analytics Welcomes 'Creative Problem Solver' as New Executive Vice President 2Health News:HRA Healthcare Research & Analytics Welcomes 'Creative Problem Solver' as New Executive Vice President 3Health News:Intercontinental Oncology Partnership Brings Access to Specialized Cancer Care to Nigeria 2Health News:Intercontinental Oncology Partnership Brings Access to Specialized Cancer Care to Nigeria 3Health News:Intercontinental Oncology Partnership Brings Access to Specialized Cancer Care to Nigeria 4Health News:Intercontinental Oncology Partnership Brings Access to Specialized Cancer Care to Nigeria 5
... In line with the International Women’s Day celebrations, an ... Apollo hospitals. Ms. J. Jayalalitha, State Chief Minister, inaugurated ... ,The health care center would cater to ... sub-acute and chronic problems. Of the health problems that ...
... and Prevention sudden infant death syndrome (SIDS) is the primary ... 1. Statistics show that about 3,000 infants die each year ... unknown. Jan-Marino Ramirez, an associate professor of organismal biology and ... study would provide an important clue that could lead to ...
... study claims that calcium intake was not associated with weight ... published in the American Journal of Clinical Nutrition. ... enrolled in the Health Professionals Follow-up Study were taken as ... between total calcium intake from diet and supplements and changes ...
... elderly man was ordered to vacate the hospital bed that he had ... court passed out ruling because this man refused to leave the hospital ... , Mr. Justice Wilkie gave the 72-year-old man 14 days to leave ... was also asked to pay ?10,000 towards the legal bill run up ...
... another Herceptin refusal case in the UK, a 10-year-old girl whose ... from her MP in order to ensure that her // mother ... treated with Herceptin, but Shropshire Primary Care Trust has not obliged ... Paterson, the MP of the region has received the letter written ...
... and with no new case cropped up in the past ... dishes on board.// ,The usual favourites like cheese ... sighted on many flights Wednesday morning. ,"Many of ... the list," said Sunil Taneja, director business development, TajSats catering ...
Cached Medicine News:Health News:Disturbance in Serotonin Levels Result in Reduced Gasping In Kids with SIDS 2
Reagent Basin, 60mL, 5/Box...
For use with 8 channel pipets....
96 channel Parallel dispenser using Positive Air Displacement Technology...
Manufacturer of the WellPro since 1992, ProGroup previously distributed the instrument through Denley and Labsystems. A direct replacement for the ProPette the WellPro performs serial dilutions in an...
Medicine Products: